Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical Home

Polypharmacy Clinical Trial

Official title:

Measure the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-entered Medical Home

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02077725
• Other study ID #: 2012H0067
• Status: Withdrawn
• Start date: December 2013

Study information

• Verified date: September 2022
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Title: Measuring the impact of an interdisciplinary polypharmacy clinic within a patient-centered medical home

Objectives:

The primary objective of this project will be to track the types of interventions made in an interdisciplinary polypharmacy clinic to improve medication regimens and medication burden. Polypharmacy has been well documented in the literature as a risk for medication errors, adverse drug events, and morbidity. Team visits, including complete medication reviews, by pharmacists and physicians within a National Committee for Quality Assurance (NCQA) tier 3 patient-centered medical home (PCMH) at an academic medical center, can improve medication regimens. Secondary objectives include (1) measuring each patient's quality of life at baseline and one month post-intervention and (2) tracking the cost of medication additions and discontinuations.

Methods:

Patients taking ten or more chronic medications will be identified for referral to the polypharmacy clinic from a report generated from the electronic medical record. The polypharmacy clinic will be staffed by a pharmacist and medical resident with oversight from an attending physician who specializes in geriatrics. Drug-related problems identified during the visit will be resolved and categorized based upon indication, efficacy, cost, safety, and compliance. The numbers and types of interventions made, both during the primary visit and anticipated in the future, will be tracked. The 12-item short form (SF-12) survey will also be administered at baseline and one month post intervention. The increase or decrease in cost for medications added and removed during these visits will be captured using the average wholesale prices.

Preliminary Results Using descriptive statistics, the types of drug-related problems identified and interventions made will be reported. Changes in quality of life and monthly medication costs will also be described.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients on 10 or more chronic medications

• Age 18 or older

Exclusion Criteria:

• Non-English speaking patients

Related Conditions & MeSH terms

• Polypharmacy

Intervention

Other:
• interdisciplinary polypharmacy clinic visit

Locations

Country	Name	City	State
United States	The Ohio State University Division of General Internal Medicine Martha Morehouse	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number and types of drug related problems identified		1 year
Secondary	Assess quality of life at baseline and one month post polypharmacy clinic visit		1 month
Secondary	Cost of medication additions and discontinuations		1 month